Receptor oligomerization guides pathway choice between proteasomal and autophagic degradation

Kefeng Lu1, Fabian den Brave1, Stefan Jentsch1

  • 1Department of Molecular Cell Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.

Nature Cell Biology
|May 16, 2017
PubMed

Insights

Protein aggregation causes neurodegenerative diseases. This study reveals yeast cells choose between proteasomal degradation and selective autophagy based on receptor properties, not just ubiquitylation, for protein quality control.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Neuroscience

Background:

  • Misfolded and aggregated proteins are cytotoxic, leading to neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Cellular protein quality control pathways, including the proteasome and selective autophagy, degrade or eliminate abnormal proteins.
  • The precise mechanisms governing the choice between these degradation pathways remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular mechanisms determining pathway choice between proteasomal degradation and selective autophagy for abnormal protein clearance.
  • To elucidate the role of ubiquitin receptors and their binding modules in directing substrates to specific degradation pathways.

Main Methods:

  • Utilized yeast models to study protein degradation pathways.
  • Employed modular artificial receptors with varying ubiquitin-binding and oligomerization potentials.
  • Analyzed substrate ubiquitylation and receptor interactions.

Main Results:

  • Pathway choice is determined after substrate ubiquitylation by competing ubiquitin receptors.
  • Autophagy receptors prevail over proteasome receptors when substrates aggregate and receptors bundle.
  • Receptor oligomerization potential, rather than ubiquitin-binding affinity, is the primary determinant of pathway selection.

Conclusions:

  • Proteasomal degradation and selective autophagy function as branches of an adaptive protein quality control system.
  • Substrate ubiquitylation serves as a common signal initiating degradation via either pathway.
  • Receptor properties, particularly oligomerization, dictate the specific route for protein clearance.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.9K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
The Proteasome02:18

The Proteasome

4.9K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.1K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.3K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.4K